رجوع
مُدرج أيضًا باسم
SBMFF
OTC
نطاق اليوم
KWD 15.89
KWD 17.65
نطاق 52 أسبوعًا
KWD 8.76
KWD 20.16
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 16.44
/
KWD 17.55
الإغلاق السابق
KWD 15.89
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 4.1 | 0.4 |
| P/B | 0.4 | 2.9 |
| ROE % | 11.2 | 3.8 |
| Net Margin % | 12.1 | 3.9 |
| Rev Growth 5Y % | 5.1 | 10.0 |
| D/E | 0.3 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2026 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
250 B | 0 |
النقاط الرئيسية
Revenue grew 5.11% annually over 5 years — modest growth
Earnings grew 50.08% over the past year
ROE of 11.21% — decent returns on equity
Debt/Equity of 0.31 — conservative balance sheet
Generating 5.22B in free cash flow
P/E of 4.06 — trading at a low valuation
النمو
Revenue Growth (5Y)
5.11%
Revenue (1Y)10.18%
Earnings (1Y)50.08%
FCF Growth (3Y)7.01%
الجودة
Return on Equity
11.21%
ROIC11.02%
Net Margin12.12%
Op. Margin21.26%
الأمان
Debt / Equity
0.31
Current Ratio1.26
Interest Coverage20.79
التقييم
P/E Ratio
4.06
P/B Ratio0.44
EV/EBITDA2.35
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 10.18% | Revenue Growth (3Y) | 5.31% |
| Earnings Growth (1Y) | 50.08% | Earnings Growth (3Y) | 17.30% |
| Revenue Growth (5Y) | 5.11% | Earnings Growth (5Y) | 6.01% |
| Profitability | |||
| Revenue (TTM) | 28.87B | Net Income (TTM) | 3.50B |
| ROE | 11.21% | ROA | 5.35% |
| Gross Margin | 81.51% | Operating Margin | 21.26% |
| Net Margin | 12.12% | Free Cash Flow (TTM) | 5.22B |
| ROIC | 11.02% | FCF Growth (3Y) | 7.01% |
| Safety | |||
| Debt / Equity | 0.31 | Current Ratio | 1.26 |
| Interest Coverage | 20.79 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 4.06 | P/B Ratio | 0.44 |
| P/S Ratio | 0.49 | PEG Ratio | 0.10 |
| EV/EBITDA | 2.35 | Dividend Yield | 0.04% |
| Market Cap | 14.21B | Enterprise Value | 14.42B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 28.87B | 26.20B | 26.03B | 26.86B | 23.65B |
| Net Income | 3.50B | 2.33B | 2.54B | 14.61B | 2.77B |
| EPS (Diluted) | 3.80 | 1.99 | 2.40 | 14.60 | 3.00 |
| Gross Profit | 23.53B | 21.21B | 21.54B | 21.53B | 18.46B |
| Operating Income | 6.14B | 5.79B | 5.59B | 5.08B | 4.19B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 65.41B | 63.60B | 64.06B | 60.54B | 47.21B |
| Total Liabilities | 22.63B | 25.43B | 26.12B | 22.81B | 24.79B |
| Shareholders' Equity | 31.96B | 30.47B | 29.75B | 30.29B | 16.75B |
| Total Debt | 9.78B | 12.58B | 13.98B | 12.12B | 14.21B |
| Cash & Equivalents | 9.57B | 9.45B | 8.65B | 9.60B | 10.62B |
| Current Assets | 24.69B | 23.81B | 25.93B | 23.50B | 22.79B |
| Current Liabilities | 19.56B | 22.61B | 20.15B | 15.35B | 10.94B |
درجات الاستراتيجيات
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026